1
0
0
(1 - 23 von 29
)
16th Annual John Goldman Conference on Chronic ...International Chronic Myeloid Leukemia Foundation
www.cml-foundation.org
Tim Brümmendorf, Steffen Koschmieder, Mirle Schemionek. Page 2. POSTER 9 : Dasatinib-‐induced reduction of tumor growth is accompanied by the changes in the ... Tim Brümmendorf, Steffen Koschmieder, Mirle Schemionek. Page 2. POSTER 9 : Dasatinib-‐induced reduction of tumor growth is accompanied by the changes in the ...
Author Barbora WeinbergerováUTP Knowledge Hub
khub.utp.edu.my
Brümmendorf, Walter Becker, Mirle Schemionek, Ralf Weiskirchen, Steffen Koschmieder, Nicolas Chatain Published Get full text. Article. Save to List. Brümmendorf, Walter Becker, Mirle Schemionek, Ralf Weiskirchen, Steffen Koschmieder, Nicolas Chatain Published Get full text. Article. Save to List.
Unfolded Protein Response in Leukemia: From Basic ...Scholars Portal Journals
journals.scholarsportal.info
Mirle Schemionek · Ralf Weiskirchen · ORCID ID · Steffen Koschmieder · ORCID ID · Nicolas Chatain · ORCID ID. Source Information. August 2021, Volume13(Issue16) ... Mirle Schemionek · Ralf Weiskirchen · ORCID ID · Steffen Koschmieder · ORCID ID · Nicolas Chatain · ORCID ID. Source Information. August 2021, Volume13(Issue16) ...
Infliximab therapy together with tyrosine kinase inhibition targets...
journals.scholarsportal.info
... Ivan G. Costa · Iris Appelmann · Fabian Beier · Tom Luedde · Till Braunschweig · Steffen Koschmieder · Tim H. Brümmendorf · Mirle Schemionek · ORCID ID ...
Full Record | Library WebsiteMacEwan University
library.macewan.ca
Author(s). Lijuan Han · Claudia Schubert · Johanna Köhler · Mirle Schemionek · Susanne Isfort · Tim H. Brümmendorf · Steffen Koschmieder · Nicolas Chatain. Hide. Author(s). Lijuan Han · Claudia Schubert · Johanna Köhler · Mirle Schemionek · Susanne Isfort · Tim H. Brümmendorf · Steffen Koschmieder · Nicolas Chatain. Hide.
Growth Factor Deprivation Combined with Prolonged ...ScienceDirect.com
www.sciencedirect.com
von A Hamilton · · Zitiert von: 2 — ... Mirle Schemionek,5,* Steffen Koschmieder, MD,6 Valerie G Brunton,7,* Tessa L Holyoake1,* 1Section of Experimental Haematology, University of Glasgow ... von A Hamilton · · Zitiert von: 2 — ... Mirle Schemionek,5,* Steffen Koschmieder, MD,6 Valerie G Brunton,7,* Tessa L Holyoake1,* 1Section of Experimental Haematology, University of Glasgow ...
Search CORECORE
core.ac.uk
... Mirle Schemionek, Junia V. Melo, Thomas Kindler, Carsten Müller-Tidow, Steffen Koschmieder and Thomas Fische. Public Library of Science (PLOS) · Crossref Mirle Schemionek, Junia V. Melo, Thomas Kindler, Carsten Müller-Tidow, Steffen Koschmieder and Thomas Fische. Public Library of Science (PLOS) · Crossref.
Intracellular retention of ABL kinase inhibitors determines ...CORE
core.ac.uk
— ... Mirle Schemionek, Junia V. Melo, Thomas Kindler, Carsten Müller-Tidow, Steffen Koschmieder and Thomas Fische. Similar works. Full text — ... Mirle Schemionek, Junia V. Melo, Thomas Kindler, Carsten Müller-Tidow, Steffen Koschmieder and Thomas Fische. Similar works. Full text.
Mast cell deficiency prevents BCR::ABL1 induced ...Nature
www.nature.com
von M Langhammer · · Zitiert von: 1 — Timo Jaquet, Henrike Jacobi, Steffen Koschmieder & Mirle Schemionek-Reinders. Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf ... von M Langhammer · · Zitiert von: 1 — Timo Jaquet, Henrike Jacobi, Steffen Koschmieder & Mirle Schemionek-Reinders. Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf ...
36 publicationsOUCI
ouci.dntb.gov.ua
Mountford, Ashley Hamilton, Mirle Schemionek, Steffen Koschmieder, Valerie G. Brunton, Tessa L. Holyoake. https://doi.org j.exphem Mountford, Ashley Hamilton, Mirle Schemionek, Steffen Koschmieder, Valerie G. Brunton, Tessa L. Holyoake. https://doi.org j.exphem
Combined BCR-ABL inhibition with lentiviral-delivered shRNA ...University of Edinburgh Research Explorer
www.research.ed.ac.uk
... Mirle Schemionek, Steffen Koschmieder, Valerie G Brunton, Tessa L Holyoake. Deanery of Molecular, Genetic and Population Health Sciences · Edinburgh Cancer Mirle Schemionek, Steffen Koschmieder, Valerie G Brunton, Tessa L Holyoake. Deanery of Molecular, Genetic and Population Health Sciences · Edinburgh Cancer ...
American Journal of Blood Researche-Century Publishing Corporation
e-century.us
Steffen Koschmieder, Mirle Schemionek: Mouse models as tools to understand and study BCR-ABL1 disease. Am J Blood Res 2011;1(1): (Full Text, PDF) ... Steffen Koschmieder, Mirle Schemionek: Mouse models as tools to understand and study BCR-ABL1 disease. Am J Blood Res 2011;1(1): (Full Text, PDF) ...
LCP1 triggers mTORC2/AKT activity and is ...Researcher | An App For Academics
www.researcher-app.com
... Mirle Schemionek, Mohamad Jawhar, Andreas Reiter, Tim H. Brümmendorf, Steffen Koschmieder, Nicolas Chatain. Hypereosinophilia (HE) is caused by a variety of Mirle Schemionek, Mohamad Jawhar, Andreas Reiter, Tim H. Brümmendorf, Steffen Koschmieder, Nicolas Chatain. Hypereosinophilia (HE) is caused by a variety of ...
Results | PLOS ONEPLOS
journals.plos.org
... Mirle Schemionek, Behzad Kharabi Masouleh, Tim H. Brümmendorf, Steffen Koschmieder, Iris Appelmann. Research Article published 04 Oct | P ... Mirle Schemionek, Behzad Kharabi Masouleh, Tim H. Brümmendorf, Steffen Koschmieder, Iris Appelmann. Research Article published 04 Oct | P
Intracellular Retention of ABL Kinase Inhibitors Determines ...PLOS
journals.plos.org
von DB Lipka · · Zitiert von: 27 — ... Mirle Schemionek, [...view 4 more...], Junia V. Melo, Thomas Kindler, Carsten Müller-Tidow, Steffen Koschmieder, Thomas Fischer [ view less ]. Daniel B ... von DB Lipka · · Zitiert von: 27 — ... Mirle Schemionek, [...view 4 more...], Junia V. Melo, Thomas Kindler, Carsten Müller-Tidow, Steffen Koschmieder, Thomas Fischer [ view less ]. Daniel B ...
Expression of cleaved PARP and BIM as proapoptotic markers ...Figshare
plos.figshare.com
— ... Mirle Schemionek, Behzad Kharabi Masouleh, Tim H. Brümmendorf, Steffen Koschmieder, Iris Appelmann. Cells were treated for 16 hours with — ... Mirle Schemionek, Behzad Kharabi Masouleh, Tim H. Brümmendorf, Steffen Koschmieder, Iris Appelmann. Cells were treated for 16 hours with ...
S1 Raw images -Figshare
figshare.com
— Mirle Schemionek, Behzad Kharabi Masouleh, Tim H. Brümmendorf, Steffen Koschmieder, Iris Appelmann. (PDF). History First online — Mirle Schemionek, Behzad Kharabi Masouleh, Tim H. Brümmendorf, Steffen Koschmieder, Iris Appelmann. (PDF). History First online ...
Ajbr
medpdfarticles.com
... to understand and study BCR-ABL1 diseases Steffen Koschmieder, Mirle Schemionek Medizinische Klinik A, Universitätsklinikum Münster, Münster, Germany.
Keywords IRE1 - Read by QxMDread.qxmd.com › keyword
read.qxmd.com
... Jörg Eschweiler, Susanne Isfort, Tim H Brümmendorf, Walter Becker, Mirle Schemionek, Ralf Weiskirchen, Steffen Koschmieder, Nicolas Chatain.
Special Issue: Hematopoietic Stem Cells X (vol 1466)www.nyas.org › annals › special-issue-hematopoieti...
www.nyas.org
... Anne Abels, Anne‐Sophie Bouillon, Matthias Begemann, Mirle Schemionek, Angela Maurer, Steffen Koschmieder, Stefan Wilop, Jens Panse, Tim H. Brümmendorf, ...
Mouse models as tools to understand and study BCR-ABL1 diseases
www.ncbi.nlm.nih.gov
Mouse models as tools to understand and study BCR-ABL1 diseases. Steffen Koschmieder and Mirle Schemionek. Medizinische Klinik A ...
accesstohe.ac.uk
pdfpharm.com
... to understand and study BCR-ABL1 diseases Steffen Koschmieder, Mirle Schemionek Medizinische Klinik A, Universitätsklinikum Münster, Münster, Germany.
ctl-lehaillan.fr
medpdfarticles.com
... to understand and study BCR-ABL1 diseases Steffen Koschmieder, Mirle Schemionek Medizinische Klinik A, Universitätsklinikum Münster, Münster, Germany.
Alle Infos zum Namen "Mirle Schemionek"
sortiert nach Relevanz / Datum